Hyderabad: IT and Industries Minister Duddilla Sridhar Babu on Tuesday unveiled an ambitious Life Sciences growth plan, setting a target of $25 billion in investments and five lakh jobs by 2030.
Inaugurating BioAsia 2026 at the Hyderabad International Convention Centre (HICC), the Minister said the State aimed to transform Hyderabad into a “Laboratory of the Future.” He added that Telangana would position the city as a global hub for innovation-led Life Sciences expansion.
Under the Life Sciences growth plan, the government formulated the Telangana Next-Gen Life Sciences Policy (2026–2030). The policy seeks to place Telangana among the top three Life Sciences clusters globally by the end of this decade.
Mr. Sridhar Babu said the global healthcare landscape was changing rapidly. He noted that India was no longer seen only as a supply base for pharmaceuticals and vaccines. Instead, it was emerging as a source of advanced scientific solutions. “Telangana is preparing for this shift — from a manufacturing base to a global centre for innovation, research and advanced drug discovery,” he said.
Hyderabad positioned at core of Life Sciences growth plan
The Minister highlighted that Hyderabad was the only Indian city featured in the CBRE Global Life Sciences Atlas (2025). He said the city stood alongside established hubs such as Boston, San Francisco, Beijing and Tokyo.
He stated that the State was strengthening research, innovation and high-end manufacturing through structured interventions. Additionally, efforts were under way to build a skilled workforce through the Telangana School of Life Sciences and Young India Skills University. These institutions will offer specialised training in mRNA technology, gene editing and AI-driven drug discovery.
The Minister also said the government introduced a dedicated policy to develop Hyderabad as a global medical tourism hub. Furthermore, he invited global enterprises and investors to partner with Telangana.
He said opportunities were available in AI-based drug discovery, automation in biologics manufacturing, precision medicine, computational biology and Bio-Manufacturing 4.0. “Telangana is ready to collaborate with global industry leaders to shape the next phase of Life Sciences innovation,” he said.
